Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

NeoDynamics - Q&A session with CEO Anna Eriksrud

By HC Andersen Capital
NeoDynamics

In this Q&A session, we will focus on the FDA’s approval of NeoDynamics innovative pulse biopsy system NeoNavia™. The US market is potentially the largest and is estimated to reach $830 million by 2025. Feel free to ask questions during the presentation. NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing the diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden. NeoNavia is evaluated for breast cancer diagnosis at leading clinics in UK, Germany, and Sweden. The pulse biopsy system has been used for tissue sampling in breast and axilla in over 500 patients. NeoDynamic´s share is listed on Nasdaq First North Growth Market Stockholm (ticker: NEOD).

*Disclaimer: HC Andersen Capital receives payment from the company for a Digital IR / Corporate Visibility subscription agreement. The content does not make recommendations to buy, sell or hold. HC Andersen Capital is an information platform that connects investors and listed companies.

Recent videos

Talenom - Planned demerger and strategies of Talenom and Easor
18.12.2025, 11.00 Talenom
HCA Morgenbørs 18/12 - Vi ser ind i en flad europæiske åbning trods markante US fald, vi undgår igen tech-nedturen
18.12.2025, 09.55 ISS
Flügger - Q2 2025/26 Analytiker video
18.12.2025, 09.46 Flügger Group
Investing in the life science sector
18.12.2025, 07.47
HCA Morgenbørs 17/12 - Vi ser ind i lidt afventende markeder ovenpå en noget svag jobmarkedsrapport
17.12.2025, 09.21 Roblon
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.